“The purpose of this measure is to develop Teraplast’s presence in Hungary and is part of the company’s strategy to boost the value of exports,” the company said.
Teraplast Bistrita has a market capitalization of RON266 million and the value of shareholders’ equity reaches RON169 million.
In the first half of 2016, Teraplast reported a profit of RON28.64 million, considering a turnover of RON131.82 million. The company reported total revenue of RON288.7 million in 2015, up 27.5% versus 2014. Its profit stood at RON28.3 million in 2015, threefold higher than the result registered in 2014.
According to data provided by the Bucharest Stock Exchange, Teraplast is owned by businessman Dorel Goia, with a 46.77% stake, while the company KJK FUND II – headquartered in Luxembourg – holds a 10% stake. The remaining shares are distributed among other investors on the Bucharest capital market.